Related Experiment Video
Updated: May 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Treatment and impact of dyslipidemia in diabetic nephropathy
Tadashi Toyama1, Miho Shimizu, Kengo Furuichi
1Division of Nephrology, Kanazawa University Hospital, Kanazawa, Japan.
Abstract:
Recent epidemiological research revealed that dyslipidemia is a risk factor for development and progression of diabetic nephropathy. Results from interventional studies revealed the possibility that anti-hyperlipidemic agents have a better effect on diabetic nephropathy through improvement of albuminuria and loss of renal function. In addition, dyslipidemia may be a consequence of albuminuria and renal dysfunction, thereby perpetuating kidney damage. Today, the proportion of diabetic patients receiving statins is increasing due to their beneficial effect on cardiovascular mortality. However, treatment for patients should be determined based on consideration of the risk and benefit of the treatment. More insight into the pathogenesis of diabetic nephropathy and the effects of life-style changes is required.
Related Concept Videos
Diabetic Nephropathy
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Retinopathy
Nephrotic Syndrome III : Nursing Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Nephrotic Syndrome II : Assessment and Medical Management
